Patents by Inventor Pietro Bruschi

Pietro Bruschi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of gamma globulin for the topical treatment of lesions of dermatitis
    Patent number: 7217416
    Abstract: The use of G class immunoglobulins, particularly immunoglobulins for intravenous use or for intramuscular use to produce a medicine for the local therapeutic treatment of dermatitis, particularly acne, contact dermatitis, atopic dermatitis, eczema and ichthyosis, psoriasis papulosquamous dermatopathies (seborrehic dermatitis, erythrodermia, etc.), as well as fungus, parasite, bacterium and virus infection dermatitis is disclosed. The pharmaceutical composition containing G class immunoglobulins suitable for topical application for the treatment of dermatitis is also disclosed.
    Type: Grant
    Filed: May 20, 2002
    Date of Patent: May 15, 2007
    Assignee: VSL Pharmaceuticals, Inc.
    Inventors: Claudio De Simone, Pietro Bruschi
  • Use of G class immunoglobulins for the topical treatment of atopic dermatitis
    Publication number: 20020192276
    Abstract: The use of G class immunoglobulins, particularly immunoglobulins for intravenous use or for intramuscular use to produce a medicine for the local therapeutic treatment of dermatitis, particularly acne, contact dermatitis, atopic dermatitis, eczema and ichthyosis, psoriasis papulosquamous dermatopathies (seborrehic dermatitis, erythrodermia, etc.), as well as fungus, parasite, bacterium and virus infection dermatitis is disclosed. The pharmaceutical composition containing G class immunoglobulins suitable for topical application for the treatment of dermatitis is also disclosed.
    Type: Application
    Filed: May 20, 2002
    Publication date: December 19, 2002
    Applicant: Mendes S.R.L.
    Inventors: Claudio De Simone, Pietro Bruschi
  • Use of G class immunoglobulins for the topical treatment of atopic dermatitis
    Patent number: 6410019
    Abstract: The use of G class immunoglobulins, particularly immunoglobulins for intravenous use or for intramuscular use to produce a medicine for the local therapeutic treatment of dermatitis, particularly acne, contact dermatitis, atopic dermatitis, eczema and ichthyosis, psoriasis, papulosquamous dermatopathies (seborrehic dermatitis, erythrodermia, etc.), as well as fungus, parasite, bacterium and virus infection dermatitis is disclosed. The pharmaceutical composition containing G class immunoglobulins suitable for topical application for the treatment of dermatitis is also disclosed.
    Type: Grant
    Filed: September 11, 1997
    Date of Patent: June 25, 2002
    Assignee: Mendes s.u.r.l.
    Inventors: Claudio De Simone, Pietro Bruschi